13F HOLDINGS REPORT
Atlas Venture Life Science Advisors, LLC
Quarter ended Q1 2023 · Filed February 14, 2023 · Accession 0001387131-23-002062
Total Value
$830.2M
Positions
17
Other Managers
0
Confidential Omitted
No
Holdings (17)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Day One Biopharmaceuticals, Inc. | DAWN | 7,568,317 | $162.9M | 19.62% |
| 2 | Kymera Therapeutics, Inc. | KYMR | 5,984,736 | $149.4M | 17.99% |
| 3 | Dyne Therapeutics, Inc. | DYN | 9,869,483 | $114.4M | 13.78% |
| 4 | Vigil Neuroscience, Inc. | 92673K108 | 5,836,874 | $73.0M | 8.79% |
| 5 | Disc Medicine, Inc. | IRON | 3,461,784 | $68.9M | 8.29% |
| 6 | Aerovate Therapeutics, Inc. | 008064107 | 2,017,521 | $59.1M | 7.12% |
| 7 | Replimune Group, Inc. | REPL | 2,098,300 | $57.1M | 6.87% |
| 8 | Third Harmonic Bio, Inc. | 88427A107 | 10,907,859 | $46.9M | 5.65% |
| 9 | Akero Therapeutics, Inc. | 00973Y108 | 594,251 | $32.6M | 3.92% |
| 10 | Generation Bio, Co. | 37148K100 | 8,278,876 | $32.5M | 3.92% |
| 11 | Ikena Oncology, Inc. | 45175G108 | 5,018,178 | $13.3M | 1.61% |
| 12 | Xilio Therapeutics, Inc. | XLO | 2,759,344 | $7.4M | 0.89% |
| 13 | F-star Therapeutics, Inc. | 30315R107 | 599,524 | $3.8M | 0.46% |
| 14 | AVROBIO INC | 05455M100 | 4,520,863 | $3.2M | 0.39% |
| 15 | Viridian Therapeutics, Inc. | VRDN | 90,072 | $2.6M | 0.32% |
| 16 | SPERO THERAPEUTICS INC | SPRO | 1,031,160 | $1.8M | 0.21% |
| 17 | MAGENTA THERAPEUTICS INC | 55910K108 | 3,476,536 | $1.4M | 0.17% |